20 March, 2019

Tetraneuron, resident company of Johnson & Johnson Innovation – JLABS

Tetraneuron, resident company of Johnson & Johnson Innovation – JLABS Tetraneuron, a spin-off of Jose M. Frade’s lab at the Cajal Institute, is a resident company […]
30 November, 2018

XVII EDITION – Farma-Biotech Program

Participation in the XVII edition of the Farma-Biotech Program Different Spanish biotechnology companies and research groups, including Tetraneuron, presented on Wednesday, November, 28, 2018, a total […]
10 October, 2018

European patent for our Therapy

Therapy: Publication of the European patent grant. On September 5, 2018, the European Patent Office granted the patent for our therapy with No. EP2783696 “Phosphorylation on the Thr-248 […]
28 September, 2018

BIOSPAIN 2018

Presenting company in BIOSPAIN 2018 Tetraneuron was selected to make a company presentation during the BIOSPAIN Congress that took place in Seville in September 25-27, 2018   […]

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.plugin cookies

ACEPTAR